Slowly progressive retinitis pigmentosa caused by two novel mutations in the MAK gene. (2018)
Attributed to:
Developing rhodopsin gene therapy to treat dominant retinitis pigmentosa
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/13816810.2018.1474369
PubMed Identifier: 29781741
Publication URI: http://europepmc.org/abstract/MED/29781741
Type: Journal Article/Review
Volume: 39
Parent Publication: Ophthalmic genetics
Issue: 4
ISSN: 1381-6810